Upper endoscopy in elderly patients: a multicentre, cross-sectional study.
Elderly
Erosion
Histology
Neoplasia
Ulcer
Upper endoscopy
Journal
Irish journal of medical science
ISSN: 1863-4362
Titre abrégé: Ir J Med Sci
Pays: Ireland
ID NLM: 7806864
Informations de publication
Date de publication:
26 Aug 2024
26 Aug 2024
Historique:
received:
08
07
2024
accepted:
31
07
2024
medline:
26
8
2024
pubmed:
26
8
2024
entrez:
26
8
2024
Statut:
aheadofprint
Résumé
Both macroscopic and histological lesions are frequently detected at upper endoscopy in elderly patients. We assessed the prevalence of main endoscopic and histological alterations in elderly (> 65 years old) patients. In this study, clinical, endoscopic and histological features of patients referred for upper endoscopy in clinical practice were retrieved. Both univariate and multivariate analyses were executed. Comparisons with previous data were performed. A total of 1336 underwent upper endoscopy in the 28 participating centres. At endoscopy, at least one macroscopic lesion was present in overall 420 (31.4%) patients. Erosive gastritis (13.3%) and erosive oesophagitis (9.8%) were the most prevalent lesions, whilst Barrett's oesophagus, gastric ulcer, duodenal ulcer and erosive duodenitis were observed in 1.8%, 2%, 1.4% and 3.1% patients, respectively. Nine (0.6%) cases of oesophageal, 25 (1.8%) gastric and 2 (0.1%) duodenal neoplasia were detected. At histology, Helicobacter pylori infection was diagnosed in 99 (15.9%) patients, and extensive precancerous lesions on gastric mucosa were detected in 80 (14.5%) patients. Endoscopic lesions were more frequent in males, at first endoscopy and in those with alarm symptoms and lower during PPI therapy. At multivariate analysis, PPI therapy significantly reduced the probability of finding endoscopic lesions (OR: 0.68, 95% CI: 0.46-0.99; P = 0.04), whilst neoplastic lesions were associated with presence of alarm symptoms (OR: 1.5, 95% CI: 1.1-2.1; P = 0.005). We found that the frequency of erosive and neoplastic lesions remained high in elderly patients, whilst the prevalence of both H. pylori infection and peptic ulcer was decreased.
Sections du résumé
BACKGROUND
BACKGROUND
Both macroscopic and histological lesions are frequently detected at upper endoscopy in elderly patients. We assessed the prevalence of main endoscopic and histological alterations in elderly (> 65 years old) patients.
METHODS
METHODS
In this study, clinical, endoscopic and histological features of patients referred for upper endoscopy in clinical practice were retrieved. Both univariate and multivariate analyses were executed. Comparisons with previous data were performed.
RESULTS
RESULTS
A total of 1336 underwent upper endoscopy in the 28 participating centres. At endoscopy, at least one macroscopic lesion was present in overall 420 (31.4%) patients. Erosive gastritis (13.3%) and erosive oesophagitis (9.8%) were the most prevalent lesions, whilst Barrett's oesophagus, gastric ulcer, duodenal ulcer and erosive duodenitis were observed in 1.8%, 2%, 1.4% and 3.1% patients, respectively. Nine (0.6%) cases of oesophageal, 25 (1.8%) gastric and 2 (0.1%) duodenal neoplasia were detected. At histology, Helicobacter pylori infection was diagnosed in 99 (15.9%) patients, and extensive precancerous lesions on gastric mucosa were detected in 80 (14.5%) patients. Endoscopic lesions were more frequent in males, at first endoscopy and in those with alarm symptoms and lower during PPI therapy. At multivariate analysis, PPI therapy significantly reduced the probability of finding endoscopic lesions (OR: 0.68, 95% CI: 0.46-0.99; P = 0.04), whilst neoplastic lesions were associated with presence of alarm symptoms (OR: 1.5, 95% CI: 1.1-2.1; P = 0.005).
CONCLUSIONS
CONCLUSIONS
We found that the frequency of erosive and neoplastic lesions remained high in elderly patients, whilst the prevalence of both H. pylori infection and peptic ulcer was decreased.
Identifiants
pubmed: 39186194
doi: 10.1007/s11845-024-03774-7
pii: 10.1007/s11845-024-03774-7
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© 2024. The Author(s), under exclusive licence to Royal Academy of Medicine in Ireland.
Références
Franceschi M, Di Mario F, Leandro G et al (2009) Acid-related disorders in the elderly. Best Pract Res Clin Gastroenterol 23(6):839–848. https://doi.org/10.1016/j.bpg.2009.10.004
doi: 10.1016/j.bpg.2009.10.004
pubmed: 19942162
Newton J (2005) Effect of age-related changes in gastric physiology on tolerability of medications for older people. Drugs Aging 22:655–661. https://doi.org/10.2466/pr0.96.3.701-706
doi: 10.2466/pr0.96.3.701-706
pubmed: 16060716
Stillhart C, Asteriadis A, Bocharova E et al (2023) The impact of advanced age on gastrointestinal characteristics that are relevant to oral drug absorption: An AGePOP review. Eur J Pharm Sci 187:106452. https://doi.org/10.1016/j.ejps.2023.106452
doi: 10.1016/j.ejps.2023.106452
pubmed: 37098371
Pilotto A, Franceschi M (2014) Helicobacter pylori infection in older people. World J Gastroenterol 20(21):6364–6373. https://doi.org/10.3748/wjg.v20.i21.6364
doi: 10.3748/wjg.v20.i21.6364
pubmed: 24914358
pmcid: 4047322
Bjarnason I, Scarpignato C, Holmgren E et al (2018) Mechanisms of damage to the gastrointestinal tract from nonsteroidal anti-inflammatory drugs. Gastroenterology 154:500–514. https://doi.org/10.1053/j.gastro.2017.10.049
doi: 10.1053/j.gastro.2017.10.049
pubmed: 29221664
Zullo A, Hassan C, Campo SM, Morini S (2007) Bleeding peptic ulcer in the elderly: risk factors and prevention strategies. Drugs Aging 24:815–828. https://doi.org/10.2165/00002512-200724100-00003
doi: 10.2165/00002512-200724100-00003
pubmed: 17896831
Keighley MR (2003) Gastrointestinal cancers in Europe. Aliment Pharmacol Ther 18(Suppl 3):7–30. https://doi.org/10.1046/j.0953-0673.2003.01722.x
doi: 10.1046/j.0953-0673.2003.01722.x
pubmed: 14531737
Pilotto A, Franceschi M, Leandro G et al (2006) Clinical features of reflux esophagitis in older people: a study of 840 consecutive patients. J Am Geriatr Soc 54(10):1537–1542. https://doi.org/10.1111/j.1532-5415.2006.00899.x
doi: 10.1111/j.1532-5415.2006.00899.x
pubmed: 17038071
Buri L, Zullo A, Hassan C et al (2013) Upper GI endoscopy in elderly patients: predictive factors of relevant endoscopic findings. Intern Emerg Med 8(2):141–146. https://doi.org/10.1007/s11739-011-0598-3
doi: 10.1007/s11739-011-0598-3
pubmed: 21538157
Zullo A, Esposito G, Ridola L et al (2014) Prevalence of lesions detected at upper endoscopy: an Italian survey. Eur J Intern Med 25(8):772–776. https://doi.org/10.1016/j.ejim.2014.08.010
doi: 10.1016/j.ejim.2014.08.010
pubmed: 25245606
Papazoglou AS, Moysidis DV, Kartas A et al (2023) Oral anticoagulation challenges and therapeutic dilemmas in the very elderly: to treat and how to treat octogenarians and nonagenarians? Pol Arch Intern Med 133(6):16508. https://doi.org/10.20452/pamw.16508
doi: 10.20452/pamw.16508
pubmed: 37227293
O’Connor HJ (2023) Forty years of Helicobacter pylori infection and changes in findings at esophagogastroduodenoscopy. Helicobacte 28(6):e13026. https://doi.org/10.1111/hel.13026
doi: 10.1111/hel.13026
Onder G, Palmer K, Carfì A et al (2019) Attitudes towards use of proton pump inhibitors among geriatricians in Italy. Eur Geriatr Med 10(5):827–831. https://doi.org/10.1007/s41999-019-00217-w
doi: 10.1007/s41999-019-00217-w
pubmed: 34652700
Drusch S, Neumann A, Michelon H et al (2023) Do proton pump inhibitors reduce upper gastrointestinal bleeding in older patients with atrial fibrillation treated with oral anticoagulants? A nationwide cohort study in France. Drugs Aging 41(1):65–76
doi: 10.1007/s40266-023-01085-7
pubmed: 38114724
pmcid: 10769917
Romano M, Gravina AG, Eusebi LH et al (2022) Management of Helicobacter pylori infection: guidelines of the Italian Society of Gastroenterology (SIGE) and the Italian Society of Digestive Endoscopy (SIED). Dig Liver Dis 54:1153–1161. https://doi.org/10.1016/j.dld.2022.06.019
doi: 10.1016/j.dld.2022.06.019
pubmed: 35831212
Malfertheiner P, Megraud F, Rokkas T et al (2022) Management of Helicobacter pylori infection: the Maastricht VI/Florence consensus report. Gut 71:1724–1762. https://doi.org/10.1136/gutjnl-2022-327745
doi: 10.1136/gutjnl-2022-327745
Bramble MG, Suvakovic Z, Hungin APS (2000) Detection of upper gastrointestinal cancer in patients taking antisecretory therapy prior to gastroscopy. Gut 46:464–467. https://doi.org/10.1136/gut.46.4.464
doi: 10.1136/gut.46.4.464
pubmed: 10716673
pmcid: 1727877
Lahner E, Zullo A, Hassan C et al (2014) Detection of gastric precancerous conditions in daily clinical practice: a nationwide survey. Helicobacter 19:417–424. https://doi.org/10.1111/hel.12149
doi: 10.1111/hel.12149
pubmed: 25231208
Lahner E, Esposito G, Zullo A et al (2016) Gastric precancerous conditions and Helicobacter pylori infection in dyspeptic patients with or without endoscopic lesions. Scand J Gastroenterol 51:1294–1298. https://doi.org/10.1080/00365521.2016.1205129
doi: 10.1080/00365521.2016.1205129
pubmed: 27442585
De Francesco V, Alicante S, Amato A et al (2022) Quality performance measures in upper gastrointestinal endoscopy for lesion detection: Italian AIGO-SIED-SIGE joint position statement. Dig Liver Dis 54:1479–1485. https://doi.org/10.1016/j.dld.2022.06.028
doi: 10.1016/j.dld.2022.06.028
pubmed: 35871984